Why the study?
Rheumatic heart disease, especially mitral stenosis, remains an important cause of maternal cardiovascular morbidity and mortality in low and middle-income countries.
Case Report (n=1)
No
Individualized medical management with beta-blockers, loop diuretics, and frequent monitoring achieved an uncomplicated pregnancy and delivery in a woman with severe rheumatic mitral stenosis and severe pulmonary hypertension who declined guideline-recommended pregnancy termination and percutaneous mitral commissurotomy.
Answers are grounded in this paper and cite their sources.
May support individualized medical management in select high-risk cases declining intervention; leaves open need for prospective data before broader adoption.
Rheumatic heart disease (RHD), and especially mitral stenosis (MS), remains an important cause of maternal cardiovascular morbidity and mortality in low and middle-income countries. A 34-year-old woman with a history of rheumatic MS presented at 14 weeks of gestational age with progressive dyspnea (NYHA functional class III). Echocardiography showed severe MS with severe pulmonary hypertension. Termination was discussed due to high maternal risk with continuation of pregnancy but the patient declined after counseling regarding maternal and fetal risks. Later at 18 weeks of gestation percutaneous transvenous mitral commissurotomy (PTMC) was suggested but was also declined. Therefore, the patient was managed with individualized medical therapy with dose adjustment and close clinical and echocardiographic follow-up. Her symptoms improved from NYHA functional class III to class II and she remained clinically stable until elective cesarean delivery at 36 weeks and 4 days in a tertiary-care center. There was not any maternal complication in pregnancy, delivery or early post-partum period and not immediate complication in the newborn. This case highlights the need for individualized medical management and careful follow-up in cases where recommended interventions are declined and that a favorable outcome in one case does not replace guideline recommended treatment.
No takes yet. Share an insight, caveat, or question.
Haghaninejad et al. (2026) conducted a case report in Pregnant woman with symptomatic severe rheumatic mitral stenosis and severe pulmonary hypertension (n=1). Individualized medical therapy (metoprolol succinate and furosemide) with close clinical and echocardiographic follow-up was evaluated on Maternal and neonatal clinical outcomes and symptom improvement (NYHA functional class) through pregnancy, delivery, and early postpartum period.
Synapse has enriched 10 related papers. Consider them for comparative context: